Triple-negative breast cancers (TNBC), forming the majority of the PAM50 criteria-classified basal-like cancer subtype, are defined by a lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression. Here, ESR1 is linked to triple-negative breast carcinoma.